AUA 2018: 3-Dimensional, Virtual Reality Planning for Robotic Partial Nephrectomy

San Francisco, CA USA ( Dr. Joseph Shirk from UCLA Medical Center presented data on using 3-dimensional, virtual reality models of patient-specific anatomy to plan for patients undergoing robotic partial nephrectomy. He foremost introduced that surgeons have mainly been using 2-dimensional CT or MRI images for the initial planning of complex surgeries such as the robotic partial nephrectomy. Contarily, he also found that previous optical and neuroscience research associated accuracy of memory with the encounter of 3-dimensional objects.

AUA 2018: Comparison of Robotic and Open Techniques in Patients Undergoing Radical Nephrectomy and Level II Inferior Vena Cava Thrombectomy

San Francisco, CA USA ( Alp Tuna Beksac from the Icahn School of Medicine at Mount Sinai, New York, NY, presented an evaluation of the safety and feasibility of robot assisted laparoscopic radical nephrectomy for patients with clinical T3 renal masses, level II IVC thrombus. As an introduction to his talk, Beksac stated that inferior vena cava (IVC) thrombectomy is a technically challenging procedure that is a relative indication for open surgery.

AUA 2018: Comparison of Robotic and Open Techniques in Patients Undergoing Radical Nephrectomy and Level II/III Inferior Vena Cava Thrombectomy

San Francisco, CA ( The boundaries of robotic surgery continue to be advanced. Recent reports have begun to explore the role of robotic surgery for the management of patients with renal cell carcinoma and IVC thrombus.  Inderbir S. Gill, MD, from USC presented on the USC experience in the open vs. robotic surgery debate at the 2017 Winter meeting of the Society of Urologic Oncology. Similarly,  the groups from NYC and Philadelphia report their experience with robotic vs. open surgery for patients with Level II/III tumor thrombus.

AUA 2018: Mini-Subcostal Incision for Open Radical Nephrectomy in the Minimally Invasive Era

San Francisco, CA ( As robotic partial nephrectomy continues to gain traction, there is increasing utilization of minimally invasive approaches to radical nephrectomy. While most institutions are comfortable with pure laparoscopic radical nephrectomy, some institutions have even begun to move to robotic radical nephrectomy. However, health care costs become a major obstacle to these novel techniques – is it cost effective to do a robotic nephrectomy when a laparoscopic nephrectomy has similar outcomes?

AUA 2018: Robotic Prostatectomy- Setbacks and Operative Solutions

San Francisco, CA ( The introduction of robotic assisted technology has had a tremendous impact in the care of patient with prostate cancer allowing surgeons to operate on the prostate with enhanced vision, control and precision. To date, robotic assisted laparoscopic radical prostatectomy (RALP) is the most common intervention for the care of patients with localized prostate cancer due to its minimal invasive approach and decreased complications compared to open radical prostatectomy. Although, robotic technology has improved the safety and reproducibility of the radical prostatectomy, complication due occur and early recognition and management of these complications is essential. Dr. Sotelo, from the University of Southern California, has assembled an all-star panel of robotic surgeons to discuss the common complication associated with robotic prostatectomy and their management. 

AUA 2018: Pure Laparoscopic Versus Robot-Assisted Partial Nephrectomy for Ct1b Renal Tumors: A Single Tertiary Center Experience

San Francisco, CA USA ( Dr. Bertolo, from the University of Turin focused on the surgical management of renal cancer with two different partial nephrectomy techniques, laparoscopic partial nephrectomy (LPN) and robotic-assisted partial nephrectomy (RAPN). He suggested that recent literature has shown a superiority in robotic versus laparoscopic surgery, however debates arise around challenging cases.

AUA 2018: Evolving Indications for Robotic Prostatectomy

San Francisco, CA ( Mani Menon, MD a leader in the field of robotics and an innovator of robotic prostatectomy, presented his vision of where robotic prostatectomy is headed.  He started by reviewing where we stand today. Many recent studies have demonstrated the quality of life (QoL) impact of definitive therapies (prostatectomy and radiation) on both urinary continence and erectile function – both are negatively impacted, and despite some recovery over time, they don’t always recover to pre-treatment levels. In contrast, active surveillance has minimal impact on these QoL outcomes. 
Page 1 of 4

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.